{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:55:49Z","timestamp":1790646949947,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09678-4","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:34:40Z","timestamp":1783388080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of tranexamic acid on early allograft dysfunction following liver transplantation: study design for a prospective randomized controlled trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Yajie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8487-3743","authenticated-orcid":false,"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"9678_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/ajt.16978","volume":"22","author":"AJ Kwong","year":"2022","unstructured":"Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, et al. OPTN\/SRTR 2020 annual data report: liver. Am J Transplant. 2022;22:204\u2013309.","journal-title":"Am J Transplant"},{"key":"9678_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1182\/blood.V71.4.1090.1090","volume":"71","author":"WH Dzik","year":"1988","unstructured":"Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood. 1988;71:1090\u20135.","journal-title":"Blood"},{"key":"9678_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/00007890-198906000-00012","volume":"47","author":"RJ Porte","year":"1989","unstructured":"Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE. Systemic effects of tissue plasminogen activator associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation. 1989;47:978\u201384.","journal-title":"Transplantation"},{"key":"9678_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/bja\/73.5.645","volume":"73","author":"A Steib","year":"1994","unstructured":"Steib A, Gengenwin N, Freys G, Boudjema K, Levy S, Otteni JC. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth. 1994;73:645\u20138.","journal-title":"Br J Anaesth"},{"key":"9678_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","volume":"135","author":"L Tengborn","year":"2015","unstructured":"Tengborn L, Blomb\u00e4ck M, Berntorp E. Tranexamic acid - an old drug still going strong and making a revival. Thromb Res. 2015;135:231\u201342.","journal-title":"Thromb Res"},{"key":"9678_CR6","doi-asserted-by":"crossref","unstructured":"CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23\u201332.","DOI":"10.1016\/S0140-6736(10)60835-5"},{"issue":"2","key":"9678_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa2215457","volume":"389","author":"CRASH-3,PATCH-Trauma Investigators and the ANZICS Clinical Trials Group","year":"2023","unstructured":"CRASH-3,PATCH-Trauma Investigators and the ANZICS Clinical Trials Group. Prehospital tranexamic acid for severe trauma. N Engl J Med. 2023;389(2):127\u201336.","journal-title":"N Engl J Med"},{"key":"9678_CR8","first-page":"29","volume":"91","author":"A Dalmau","year":"2000","unstructured":"Dalmau A, Sabat\u00e9 A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg. 2000;91:29\u201334.","journal-title":"Anesth Analg"},{"issue":"10","key":"9678_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/lt.20075","volume":"2004","author":"A Dalmau","year":"2004","unstructured":"Dalmau A, Sabate A, Koo M, Bartolome C, Rafecas A, Figueras J, et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparitive study. Liver Transpl. 2004;2004(10):279\u201384.","journal-title":"Liver Transpl"},{"key":"9678_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1600-6143.2006.01591.x","volume":"7","author":"IQ Molenaar","year":"2007","unstructured":"Molenaar IQ, Warnaar N, Groen H, TenVergert EM, Sloof MJH, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2007;7:185\u201394.","journal-title":"Am J Transplant"},{"issue":"7","key":"9678_CR11","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1097\/TP.0000000000001682","volume":"101","author":"A Badenoch","year":"2017","unstructured":"Badenoch A, Sharma A, Gower S, Selzner M, Srinivas C, W\u0105sowicz M, et al. The effectiveness and safety of tranexamic acid in orthotopic liver transplantation clinical practice: a propensity score matched cohort study. Transplantation. 2017;101(7):1658\u201365.","journal-title":"Transplantation"},{"key":"9678_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00007890-199808150-00005","volume":"66","author":"M Deschenes","year":"1998","unstructured":"Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation. 1998;66:302\u201310.","journal-title":"Transplantation"},{"key":"9678_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/lt.22091","volume":"16","author":"KM Olthoff","year":"2010","unstructured":"Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16:943\u20139.","journal-title":"Liver Transpl"},{"key":"9678_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.transproceed.2012.01.115","volume":"44","author":"KP Croome","year":"2012","unstructured":"Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, et al. Should a lower quality organ go to the least sick patient? Model for endstage liver disease score and donor risk index as predictors of early allograft dysfunction. Transplant Proc. 2012;44:1303\u20136.","journal-title":"Transplant Proc"},{"key":"9678_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12887","volume":"31","author":"J Hudcova","year":"2017","unstructured":"Hudcova J, Scopa C, Rashid J, Waqas A, Ruthazer R, Schumann R. Effect of early allograft dysfunction on outcomes following liver transplantation. Clin Transpl. 2017;31:e12887.","journal-title":"Clin Transpl"},{"key":"9678_CR16","doi-asserted-by":"crossref","unstructured":"Adam R, Karam V, Delvart V, O'Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57:675\u201388.","DOI":"10.1016\/j.jhep.2012.04.015"},{"key":"9678_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5604\/16652681.1184212","volume":"15","author":"DD Lee","year":"2016","unstructured":"Lee DD, Croome KP, Shalev JA, Musto KR, Sharma M, Keaveny AP, et al. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Ann Hepatol. 2016;15:53\u201360.","journal-title":"Ann Hepatol"},{"key":"9678_CR18","doi-asserted-by":"publisher","first-page":"296e","DOI":"10.1002\/lt.500010505","volume":"1","author":"T Piratvisuth","year":"1995","unstructured":"Piratvisuth T, Tredger JM, Hayllar KA, Williams R. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. Liver Transpl Surg. 1995;1:296e\u2013301.","journal-title":"Liver Transpl Surg"},{"key":"9678_CR19","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/TP.0000000000003877","volume":"105","author":"C Quintini","year":"2021","unstructured":"Quintini C, Muiesan P, Detry O, Gastaca M, de Jonge J, Clavien PA, et al. Early allograft dysfunction and complications in DCD liver transplantation: expert consensus statements from the International Liver Transplantation Society. Transplantation. 2021;105:1643\u201352.","journal-title":"Transplantation"},{"issue":"1","key":"9678_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.transproceed.2020.02.168","volume":"53","author":"J Hudcova","year":"2021","unstructured":"Hudcova J, Qasmi ST, Ruthazer R, Waqas A, Haider SB, Schumann R. Early allograft dysfunction following liver transplant: impact of obesity, diabetes, and red blood cell transfusion. Transplant Proc. 2021;53(1):119\u201323.","journal-title":"Transplant Proc"},{"issue":"4","key":"9678_CR21","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO\u2002clinical\u2002practice\u2002guidelines\u2002for\u2002acute\u2002kidney\u2002injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"9678_CR22","first-page":"287","volume":"7","author":"L Chuan","year":"2016","unstructured":"Chuan L, Ming Z, Lyunan Y, Bo L, Yong Z, Tianfu W, et al. Clinical experience analysis of liver transplantation from donation after citizen\u2019s death in 78 cases. Organ Transplantation. 2016;7(4):287\u201391.","journal-title":"Organ Transplantation"},{"key":"9678_CR23","doi-asserted-by":"crossref","unstructured":"Bharathan VK, Chandran B, Gopalakrishnan U, Varghese CT, Menon RN, Balakrishnan D, et al. Perioperative\u2002prostaglandin\u2002e1\u2002infusion\u2002in\u2002living\u2002donor\u2002liver\u2002transplantation: a double-blind, placebo-controlled randomized trial. Liver Transpl. 2016;22(8):1067\u201374.","DOI":"10.1002\/lt.24479"},{"key":"9678_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/00000542-199611000-00012","volume":"85","author":"JF Boylan","year":"1996","unstructured":"Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. 1996;85:1043\u20138.","journal-title":"Anesthesiology"},{"key":"9678_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-0012.1993.tb00722.x","volume":"7","author":"K Yassen","year":"1993","unstructured":"Yassen K, Bellamy MC, Sadek SA, Webster NR. Tranexamic reduces blood loss during orthotopic liver transplantation. Clin Transplant. 1993;7:453\u20138.","journal-title":"Clin Transplant"},{"key":"9678_CR26","first-page":"281","volume":"85","author":"M Spar","year":"1997","unstructured":"Spar M, Ramsay MA, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ. Continuous smalldose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg. 1997;85:281\u20135.","journal-title":"Anesth Analg"},{"key":"9678_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/bja\/80.5.685","volume":"80","author":"M Manji","year":"1998","unstructured":"Manji M, Isaac JL, Bion J. Survival from massive intraoperative pulmonary thromboembolism during orthotopic liver transplantation. Br J Anaesth. 1998;80:685\u20137.","journal-title":"Br J Anaesth"},{"key":"9678_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1053\/jlts.2001.26928","volume":"7","author":"E Gologorsky","year":"2001","unstructured":"Gologorsky E, De Wolf AM, Scott V, et al. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl. 2001;7:783\u20139.","journal-title":"Liver Transpl"},{"key":"9678_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/lt.20064","volume":"10","author":"MA Ramsay","year":"2004","unstructured":"Ramsay MA, Randall HB, Burton EC. Intravascular thrombosis and thromboembolism during liver transplantation: antifibrinolytic therapy implicated? Liver Transpl. 2004;10:310\u20134.","journal-title":"Liver Transpl"},{"issue":"3","key":"9678_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/MBC.0000000000000733","volume":"29","author":"EH Kim","year":"2018","unstructured":"Kim EH, Ko JS, Gwak MS, Lee SK, Kim GS. Incidence and clinical significance of hyperfibrinolysis during living donor liver transplantation. Blood Coagul Fibrinolysis. 2018;29(3):322\u20136.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"9678_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S2468-1253(22)00268-0","volume":"8","author":"JM Pollok","year":"2023","unstructured":"Pollok JM, Tinguely P, Berenguer M, Niemann CU, Raptis DA, Spiro M, et al. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023;8(1):81\u201394.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"9678_CR32","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","volume":"23","author":"AJ Kwong","year":"2023","unstructured":"Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, et al. OPTN\/SRTR 2021 Annual Data Report: Liver. Am J Transplant. 2023;23:S178-263.","journal-title":"Am J Transplant"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09678-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09678-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09678-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:02:56Z","timestamp":1790643776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09678-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9678"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09678-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the ethics committee of West China Hospital, Sichuan University (project number: 2023\u20132211). All participating patients will provide written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate {24}","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors gave their consent for publication. The model of our consent form will be provided on request.","order":2,"name":"Ethics","label":"Consent for publication {32}","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests {28}","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"586"}}